Dr. Basil Alwattar, MD

Dr. Alwattar practices at California Sports and Orthopaedic in Oakland, California.

Dr. Alwattar's NPI, 1700081502, was assigned on June 20, 2007. Dr. Alwattar graduated from University of Illinois College of Medicine - Chicago in 2004. Dr. Alwattar's California license number on file is A112912.

Dr. Alwattar's primary practice is California Sports and Orthopaedic, at 350 30th St, Oakland, CA 94609 in Alameda County. The practice phone is (510) 422-5150.

Dr. Alwattar's primary practice is California Sports and Orthopaedic in Oakland, California. Dr. Alwattar is also affiliated with Alta Bates Summit Medical Center. The medical group on file is Palo Alto Foundation Medical Group. Dmand AI also links Dr. Alwattar to 2 more hospitals, 4 home health agencies, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alwattar practices, 10 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Alwattar's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Alwattar is board certified in orthopaedic sports medicine by the American Board of Orthopaedic Surgery. Dmand AI has Dr. Alwattar's licenses on file in 2 states: California and New York.

Dmand AI lists arthritis, bursitis, hip replacement, joint arthropathy, joint pain, knee arthroscopy, knee injury and knee replacement among the conditions Dr. Alwattar treats.

CMS data shows 2,482 Medicare services from Dr. Alwattar across 19 procedure codes in 2024, for 500 Medicare patients. Medicare paid $254,005 for them.

CMS counts 500 Medicare patients who saw Dr. Alwattar in 2024. The largest group is 75 to 84, with 232 patients. 75% of them have arthritis, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.03, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Alwattar's median patient age at 69, with 58% women.

In 2024, Dr. Alwattar wrote 503 Medicare Part D claims for 177 patients. 84% of them were for generic drugs. CMS names the drug for 455 of them, across 6 drugs with 11 or more claims each, at $24,310 in total drug cost. In 2023, CMS named 474 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Alwattar for performance year 2024, reported as part of a group. Dr. Alwattar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Alwattar as offering telehealth. CMS counts 55 procedures of hip replacement by Dr. Alwattar, more than 89% of the clinicians it reports for that procedure.

Lower limb (leg) arthroscopy (minimally invasive joint repair): 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Alwattar. Dr. Alwattar has published most often in Bull NYU Hosp Jt Dis. Dr. Alwattar's most frequent co-authors are Ran Schwarzkopf, MD, MSc and Nirmal C. Tejwani, MD.

CMS Open Payments shows 226 general payments to Dr. Alwattar from 19 drug and device companies from 2016 to 2025. Education make up the largest share, 42% of the total. Evolution Surgical, Inc paid the most, $11,938.

Dr. Alwattar graduated from University of Illinois College of Medicine - Chicago in 2004.

Dr. Alwattar is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.